首页 > 最新文献

Infectious microbes & diseases最新文献

英文 中文
The group A Streptococcus interleukin-8 protease SpyCEP promotes bacterial intracellular survival by evasion of autophagy. A群链球菌白细胞介素-8蛋白酶SpyCEP通过逃避自噬促进细菌胞内存活。
Q3 INFECTIOUS DISEASES Pub Date : 2022-09-01 DOI: 10.1097/im9.0000000000000098
René Bergmann, Giuseppe Gulotta, Federica Andreoni, Tomoko Sumitomo, Shigetada Kawabata, Annelies S Zinkernagel, Gursharan S Chhatwal, Victor Nizet, Manfred Rohde, Satoshi Uchiyama

Autophagy serves an innate immune function in defending the host against invading bacteria, including group A Streptococcus (GAS). Autophagy is regulated by numerous host proteins, including the endogenous negative regulator calpain, a cytosolic protease. Globally disseminated serotype M1T1 GAS strains associated with high invasive disease potential express numerous virulence factors and resist autophagic clearance. Upon in vitro infection of human epithelial cell lines with representative wild-type GAS M1T1 strain 5448 (M1.5448), we observed increased calpain activation linked to a specific GAS virulence factor, the IL-8 protease SpyCEP. Calpain activation inhibited autophagy and decreased capture of cytosolic GAS in autophagosomes. In contrast, the serotype M6 GAS strain JRS4 (M6.JRS4), which is highly susceptible to host autophagy-mediated killing, expresses low levels of SpyCEP and does not activate calpain. Overexpression of SpyCEP in M6.JRS4 stimulated calpain activation, inhibited autophagy and significantly decreased bacterial capture in autophagosomes. These paired loss- and gain-of-function studies reveal a novel role for the bacterial protease SpyCEP in enabling GAS M1 evasion of autophagy and host innate immune clearance.

自噬在保护宿主免受入侵细菌(包括A群链球菌(GAS))的侵害方面具有先天免疫功能。自噬受多种宿主蛋白调控,包括内源性负调节因子钙蛋白酶(一种胞质蛋白酶)。全球传播的血清型M1T1 GAS菌株与高侵袭性疾病相关,表达多种毒力因子并抵抗自噬清除。在体外感染具有代表性的野生型GAS M1T1菌株5448 (M1.5448)的人上皮细胞系后,我们观察到与特定GAS毒力因子IL-8蛋白酶SpyCEP相关的calpain激活增加。激活钙蛋白酶抑制自噬,减少自噬小体中胞质GAS的捕获。相比之下,血清型M6 GAS菌株JRS4 (M6.JRS4)对宿主自噬介导的杀伤高度敏感,表达低水平的SpyCEP,不激活calpain。SpyCEP在M6中的过表达。JRS4刺激calpain活化,抑制自噬,显著降低自噬体中的细菌捕获。这些配对的功能丧失和功能获得的研究揭示了细菌蛋白酶SpyCEP在使GAS M1逃避自噬和宿主先天免疫清除中的新作用。
{"title":"The group A <i>Streptococcus</i> interleukin-8 protease SpyCEP promotes bacterial intracellular survival by evasion of autophagy.","authors":"René Bergmann,&nbsp;Giuseppe Gulotta,&nbsp;Federica Andreoni,&nbsp;Tomoko Sumitomo,&nbsp;Shigetada Kawabata,&nbsp;Annelies S Zinkernagel,&nbsp;Gursharan S Chhatwal,&nbsp;Victor Nizet,&nbsp;Manfred Rohde,&nbsp;Satoshi Uchiyama","doi":"10.1097/im9.0000000000000098","DOIUrl":"https://doi.org/10.1097/im9.0000000000000098","url":null,"abstract":"<p><p>Autophagy serves an innate immune function in defending the host against invading bacteria, including group A <i>Streptococcus</i> (GAS). Autophagy is regulated by numerous host proteins, including the endogenous negative regulator calpain, a cytosolic protease. Globally disseminated serotype M1T1 GAS strains associated with high invasive disease potential express numerous virulence factors and resist autophagic clearance. Upon in vitro infection of human epithelial cell lines with representative wild-type GAS M1T1 strain 5448 (M1.5448), we observed increased calpain activation linked to a specific GAS virulence factor, the IL-8 protease SpyCEP. Calpain activation inhibited autophagy and decreased capture of cytosolic GAS in autophagosomes. In contrast, the serotype M6 GAS strain JRS4 (M6.JRS4), which is highly susceptible to host autophagy-mediated killing, expresses low levels of SpyCEP and does not activate calpain. Overexpression of SpyCEP in M6.JRS4 stimulated calpain activation, inhibited autophagy and significantly decreased bacterial capture in autophagosomes. These paired loss- and gain-of-function studies reveal a novel role for the bacterial protease SpyCEP in enabling GAS M1 evasion of autophagy and host innate immune clearance.</p>","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 3","pages":"116-123"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275413/pdf/nihms-1867112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bicarbonate Effects on Antibacterial Immunity and Mucus Glycobiology in the Cystic Fibrosis Lung: A Review With Selected Experimental Observations. 碳酸氢盐对囊性纤维化肺的抗菌免疫和粘液糖生物学的影响:部分实验观察的综述。
Q3 INFECTIOUS DISEASES Pub Date : 2022-09-01 DOI: 10.1097/im9.0000000000000101
Ruth Siew, Tzung-Lin Ou, Samira Dahesh, Kathryn Akong, Victor Nizet

The primary defect in cystic fibrosis (CF) is abnormal chloride and bicarbonate transport in the cystic fibrosis transmembrane conductance regulator (CFTR) epithelial ion channel. The apical surface of the respiratory tract is lined by an airway surface liquid layer (ASL) composed of mucin comprising mainly MUC5A and MUC5B glycoproteins. ASL homeostasis depends on sodium bicarbonate secretion into the airways and secretion deficits alter mucus properties leading to airway obstruction, inflammation, and infections. Downstream effects of abnormal ion transport in the lungs include altered intrinsic immune defenses. We observed that neutrophils killed Pseudomonas aeruginosa more efficiently when it had been exposed to sodium bicarbonate, and formation of neutrophil extracellular traps (NETs) by neutrophils was augmented in the presence of increasing bicarbonate concentrations. Physiological levels of bicarbonate sensitized P. aeruginosa to the antimicrobial peptide cathelicidin LL-37, which is present in both lung ASL and in NETs. Sodium bicarbonate has various uses in clinical medicine and in the care of CF patients, and could be further explored as a therapeutic adjunct against Pseudomonas infections.

囊性纤维化(CF)的主要缺陷是囊性纤维化跨膜传导调节剂(CFTR)上皮离子通道中氯离子和碳酸氢盐转运异常。呼吸道的顶端表面有一层由粘蛋白组成的气道表面液层(ASL),主要由MUC5A和MUC5B糖蛋白组成。ASL的内稳态依赖于碳酸氢钠分泌到气道,分泌不足会改变粘液特性,导致气道阻塞、炎症和感染。肺中异常离子运输的下游效应包括改变内在免疫防御。我们观察到中性粒细胞在暴露于碳酸氢钠时更有效地杀死铜绿假单胞菌,并且在碳酸氢钠浓度增加的情况下,中性粒细胞形成的中性粒细胞胞外陷阱(NETs)增加。生理水平的碳酸氢盐使P. aeruginosa对抗菌肽cathelicidin LL-37敏感,该肽存在于肺ASL和NETs中。碳酸氢钠在临床医学和CF患者的护理中有多种用途,可以进一步探索作为假单胞菌感染的治疗辅助药物。
{"title":"Bicarbonate Effects on Antibacterial Immunity and Mucus Glycobiology in the Cystic Fibrosis Lung: A Review With Selected Experimental Observations.","authors":"Ruth Siew,&nbsp;Tzung-Lin Ou,&nbsp;Samira Dahesh,&nbsp;Kathryn Akong,&nbsp;Victor Nizet","doi":"10.1097/im9.0000000000000101","DOIUrl":"https://doi.org/10.1097/im9.0000000000000101","url":null,"abstract":"<p><p>The primary defect in cystic fibrosis (CF) is abnormal chloride and bicarbonate transport in the cystic fibrosis transmembrane conductance regulator (CFTR) epithelial ion channel. The apical surface of the respiratory tract is lined by an airway surface liquid layer (ASL) composed of mucin comprising mainly MUC5A and MUC5B glycoproteins. ASL homeostasis depends on sodium bicarbonate secretion into the airways and secretion deficits alter mucus properties leading to airway obstruction, inflammation, and infections. Downstream effects of abnormal ion transport in the lungs include altered intrinsic immune defenses. We observed that neutrophils killed <i>Pseudomonas aeruginosa</i> more efficiently when it had been exposed to sodium bicarbonate, and formation of neutrophil extracellular traps (NETs) by neutrophils was augmented in the presence of increasing bicarbonate concentrations. Physiological levels of bicarbonate sensitized <i>P. aeruginosa</i> to the antimicrobial peptide cathelicidin LL-37, which is present in both lung ASL and in NETs. Sodium bicarbonate has various uses in clinical medicine and in the care of CF patients, and could be further explored as a therapeutic adjunct against <i>Pseudomonas</i> infections.</p>","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 3","pages":"103-110"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928163/pdf/nihms-1827705.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9639310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introducing the New Versions of Chinese Diagnosis and Treatment Protocol for COVID-19 新冠肺炎中国诊疗方案新版本介绍
Q3 INFECTIOUS DISEASES Pub Date : 2022-08-04 DOI: 10.1097/im9.0000000000000099
Qiong Zhang
Since the first outbreak of COVID-19 in January 2020, the pandemic has lasted already for 21⁄2 years, causing 564,126,546 confirmed infections and 6,371,354 confirmed deaths worldwide by July 22, 2022. In addition to the large number of deaths caused by the disease, the COVID-19 pandemic has also had a huge impact on the world economy. Not only have the transportation, tourism, catering, cultural and entertainment industries, and other personnel-intensive industries been directly impacted, but also a large number of people have been isolated and controlled or accepted home office work, which in turn affected all walks of life. According to the World Economic Outlook Report released by the International Monetary Fund in October 2021, the world economy has declined by 3.1% year-on-year in 2020, of which developed economies has declined by 4.5% and emerging market and developing economies by 2.1%. In the process of containing the COVID-19 epidemic, different countries have adopted different antiepidemic strategies, and the results achieved have been variable. China's antiepidemic containment strategies have proven highly effective. Wuhan, as the city where the outbreak was first reported, faced the rapid dissemination of an unknown pathogen. After the initial chaos, the situation was quickly stabilized with the support of personnel and materials from all over the country. Under the organization of the Chinese National Health Commission, the experience and lessons of epidemic prevention and control and clinical treatment have continuously been summarized and updated in national guidelines. Between January 16 and March 3, 2020, eight versions (the Trial Versions 1 to 7 and the Revised Trial Version 5) of theDiagnosis and Treatment Protocol for COVID-19 have been released and updatedwithin a short period
自2020年1月首次爆发COVID-19以来,这场大流行已经持续了21年半,截至2022年7月22日,全球已造成564,126,546例确诊感染和6371,354例确诊死亡。新冠肺炎大流行除了造成大量死亡外,还对世界经济产生了巨大影响。不仅交通、旅游、餐饮、文化娱乐等人员密集型产业受到直接冲击,而且大量人员被隔离控制或接受居家办公,进而影响各行各业。根据国际货币基金组织2021年10月发布的《世界经济展望报告》,2020年世界经济同比下降3.1%,其中发达经济体下降4.5%,新兴市场和发展中经济体下降2.1%。在疫情防控过程中,各国采取了不同的防控策略,取得的效果参差不齐。事实证明,中国的疫情防控战略非常有效。作为首次报告疫情的城市,武汉面临着一种未知病原体的迅速传播。在最初的混乱之后,在来自全国各地的人员和物资的支持下,局势迅速稳定下来。在中国国家卫生健康委员会的组织下,国家指南不断总结和更新疫情防控和临床治疗的经验教训。2020年1月16日至3月3日期间,发布了八个版本的《新冠肺炎诊疗方案》(试验版本1至7和修订的试验版本5),并在短时间内进行了更新
{"title":"Introducing the New Versions of Chinese Diagnosis and Treatment Protocol for COVID-19","authors":"Qiong Zhang","doi":"10.1097/im9.0000000000000099","DOIUrl":"https://doi.org/10.1097/im9.0000000000000099","url":null,"abstract":"Since the first outbreak of COVID-19 in January 2020, the pandemic has lasted already for 21⁄2 years, causing 564,126,546 confirmed infections and 6,371,354 confirmed deaths worldwide by July 22, 2022. In addition to the large number of deaths caused by the disease, the COVID-19 pandemic has also had a huge impact on the world economy. Not only have the transportation, tourism, catering, cultural and entertainment industries, and other personnel-intensive industries been directly impacted, but also a large number of people have been isolated and controlled or accepted home office work, which in turn affected all walks of life. According to the World Economic Outlook Report released by the International Monetary Fund in October 2021, the world economy has declined by 3.1% year-on-year in 2020, of which developed economies has declined by 4.5% and emerging market and developing economies by 2.1%. In the process of containing the COVID-19 epidemic, different countries have adopted different antiepidemic strategies, and the results achieved have been variable. China's antiepidemic containment strategies have proven highly effective. Wuhan, as the city where the outbreak was first reported, faced the rapid dissemination of an unknown pathogen. After the initial chaos, the situation was quickly stabilized with the support of personnel and materials from all over the country. Under the organization of the Chinese National Health Commission, the experience and lessons of epidemic prevention and control and clinical treatment have continuously been summarized and updated in national guidelines. Between January 16 and March 3, 2020, eight versions (the Trial Versions 1 to 7 and the Revised Trial Version 5) of theDiagnosis and Treatment Protocol for COVID-19 have been released and updatedwithin a short period","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"83 - 84"},"PeriodicalIF":0.0,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43347147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Early Warning and Monitoring of Coronavirus Disease 2019 Using Baidu Search Index and Baidu Information Index in Guangxi, China 基于百度检索索引和百度信息索引的2019冠状病毒病预警与监测
Q3 INFECTIOUS DISEASES Pub Date : 2022-08-04 DOI: 10.1097/IM9.0000000000000100
Yihong Xie, Wanwan Zhou, Jinhui Zhu, Y. Ruan, Xiaoming Wang, Tengda Huang
Abstract Coronavirus disease 2019 (COVID-19) is an emerging infectious disease, and it is important to detect early and monitor the disease trend for policymakers to make informed decisions. We explored the predictive utility of Baidu Search Index and Baidu Information Index for early warning of COVID-19 and identified search keywords for further monitoring of epidemic trends in Guangxi. A time-series analysis and Spearman correlation between the daily number of cases and both the Baidu Search Index and Baidu Information Index were performed for seven keywords related to COVID-19 from January 8 to March 9, 2020. The time series showed that the temporal distributions of the search terms “coronavirus,” “pneumonia” and “mask” in the Baidu Search Index were consistent and had 2 to 3 days' lead time to the reported cases; the correlation coefficients were higher than 0.81. The Baidu Search Index volume in 14 prefectures of Guangxi was closely related with the number of reported cases; it was not associated with the local GDP. The Baidu Information Index search terms “coronavirus” and “pneumonia” were used as frequently as 192,405.0 and 110,488.6 per million population, respectively, and they were also significantly associated with the number of reported cases (rs > 0.6), but they fluctuated more than for the Baidu Search Index and had 0 to 14 days' lag time to the reported cases. The Baidu Search Index with search terms “coronavirus,” “pneumonia” and “mask” can be used for early warning and monitoring of the epidemic trend of COVID-19 in Guangxi, with 2 to 3 days' lead time.
摘要2019冠状病毒病(COVID-19)是一种新兴传染病,早期发现并监测疫情趋势对决策者做出明智决策具有重要意义。探讨百度搜索指数和百度信息指数在新冠肺炎预警中的预测效用,确定搜索关键词,为进一步监测广西疫情趋势提供依据。对2020年1月8日至3月9日与COVID-19相关的7个关键词进行日病例数与百度搜索指数和百度信息指数的时间序列分析和Spearman相关性分析。时间序列显示,百度搜索索引中“冠状病毒”、“肺炎”和“口罩”搜索词的时间分布一致,与报告病例的时间间隔为2 ~ 3天;相关系数均大于0.81。广西14个地州的百度搜索量与报告病例数密切相关;它与当地的GDP无关。百度信息指数搜索词“冠状病毒”和“肺炎”的使用频率分别为192405.0 /百万人口和110488.6 /百万人口,它们也与报告病例数显著相关(rs > 0.6),但它们比百度搜索指数波动更大,与报告病例有0到14天的滞后时间。以“冠状病毒”、“肺炎”、“口罩”为搜索词的百度搜索指数可用于广西新冠肺炎疫情趋势预警和监测,提前2 - 3天。
{"title":"Early Warning and Monitoring of Coronavirus Disease 2019 Using Baidu Search Index and Baidu Information Index in Guangxi, China","authors":"Yihong Xie, Wanwan Zhou, Jinhui Zhu, Y. Ruan, Xiaoming Wang, Tengda Huang","doi":"10.1097/IM9.0000000000000100","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000100","url":null,"abstract":"Abstract Coronavirus disease 2019 (COVID-19) is an emerging infectious disease, and it is important to detect early and monitor the disease trend for policymakers to make informed decisions. We explored the predictive utility of Baidu Search Index and Baidu Information Index for early warning of COVID-19 and identified search keywords for further monitoring of epidemic trends in Guangxi. A time-series analysis and Spearman correlation between the daily number of cases and both the Baidu Search Index and Baidu Information Index were performed for seven keywords related to COVID-19 from January 8 to March 9, 2020. The time series showed that the temporal distributions of the search terms “coronavirus,” “pneumonia” and “mask” in the Baidu Search Index were consistent and had 2 to 3 days' lead time to the reported cases; the correlation coefficients were higher than 0.81. The Baidu Search Index volume in 14 prefectures of Guangxi was closely related with the number of reported cases; it was not associated with the local GDP. The Baidu Information Index search terms “coronavirus” and “pneumonia” were used as frequently as 192,405.0 and 110,488.6 per million population, respectively, and they were also significantly associated with the number of reported cases (rs > 0.6), but they fluctuated more than for the Baidu Search Index and had 0 to 14 days' lag time to the reported cases. The Baidu Search Index with search terms “coronavirus,” “pneumonia” and “mask” can be used for early warning and monitoring of the epidemic trend of COVID-19 in Guangxi, with 2 to 3 days' lead time.","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"168 - 174"},"PeriodicalIF":0.0,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45717982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation: Diagnosis and Treatment Protocol for COVID-19 (Revised Trial Version 8) 《新冠肺炎诊疗方案(试行修订第8版)》
Q3 INFECTIOUS DISEASES Pub Date : 2022-07-28 DOI: 10.1097/IM9.0000000000000094
Anonymous
series of active control and treatment measures, the epidemic situation in contained effectively. the pandemic persists globally, the risk for the pandemic transmission and spread in China remains. Currently, the administration of COVID-19 vaccines is carried out systematically worldwide, with novel coronavirus (2019-nCov)-specific antibodies detected in most vaccinated individuals. In order to further strengthen the diagnosis and treatment of COVID-19, we revised the Diagnosis and Treatment Protocol for COVID-19 (Trial Version 8) to Diagnosis and Treatment Protocol for COVID-19 (Revised Trial Version 8)
一系列积极防控措施,疫情得到有效遏制。疫情在全球范围内持续存在,在中国境内传播扩散的风险依然存在。目前,在世界范围内系统地进行了COVID-19疫苗接种,在大多数接种疫苗的个体中检测到新型冠状病毒(2019-nCov)特异性抗体。为进一步加强新冠肺炎诊疗工作,我们将《新冠肺炎诊疗方案(试行8版)》修订为《新冠肺炎诊疗方案(试行8版修订)》。
{"title":"Translation: Diagnosis and Treatment Protocol for COVID-19 (Revised Trial Version 8)","authors":"Anonymous","doi":"10.1097/IM9.0000000000000094","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000094","url":null,"abstract":"series of active control and treatment measures, the epidemic situation in contained effectively. the pandemic persists globally, the risk for the pandemic transmission and spread in China remains. Currently, the administration of COVID-19 vaccines is carried out systematically worldwide, with novel coronavirus (2019-nCov)-specific antibodies detected in most vaccinated individuals. In order to further strengthen the diagnosis and treatment of COVID-19, we revised the Diagnosis and Treatment Protocol for COVID-19 (Trial Version 8) to Diagnosis and Treatment Protocol for COVID-19 (Revised Trial Version 8)","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"85 - 93"},"PeriodicalIF":0.0,"publicationDate":"2022-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43183925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
An Epidemiologic Analysis of Vulvovaginal Candidiasis and Antifungal Susceptibilities 外阴阴道念珠菌感染及耐药性的流行病学分析
Q3 INFECTIOUS DISEASES Pub Date : 2022-07-26 DOI: 10.1097/IM9.0000000000000095
Fadile Gaye Hösükoğlu, F. Ekşi, Mehmet Erinmez, M. Uğur
Abstract Inflammation of the vagina and vulva caused by Candida is called vulvovaginal candidiasis (VVC). Risk factors for VVC include pregnancy, diabetes mellitus, frequent oral sexual intercourse, and the use of tight synthetic underwear and systemic antibiotics. Candida albicans, which belongs to the normal flora of the vagina, is the most common cause of VVC. However, an increase in VVC episodes caused by non-albicans Candida species, including Candida glabrata, Candida tropicalis, Candida krusei and Candida parapsilosis, has been reported. In this study, a total of 100 Candida isolates obtained from patients with vaginitis symptoms were evaluated. The susceptibility of the Candida strains to amphotericin B, itraconazole, fluconazole, ketoconazole, voriconazole and caspofungin was investigated using the reference broth microdilution method. Risk factors and demographic characteristics of the patients and the identified Candida species were also investigated. Among the 100 Candida strains isolated from vaginal samples, 47 (47%) were C. albicans, 43 (43%) C. glabrata, 5 (5%) C. kefyr, 2 (2%) C. krusei, 2 (2%) C. tropicalis and 1 (1%) was Candida guilliermondii. The incidences of Candida susceptibility to caspofungin, fluconazole, itraconazole, voriconazole, ketoconazole and amphotericin B were 75%, 35%, 27%, 80%, 97% and 100%, respectively. Also, there was a significant difference in antifungal susceptibility among patients belonging to certain risk groups, such as patients previously using antibiotics and recurrent cases. Prevalence of non-albicans Candida species and antifungal resistance, especially against azoles, are both increasing, and certain risk factors should be monitored strictly.
念珠菌引起的阴道和外阴炎症称为外阴阴道念珠菌病(VVC)。VVC的危险因素包括妊娠、糖尿病、频繁口交、使用紧身合成内衣和全身抗生素。白色念珠菌属于阴道正常菌群,是VVC最常见的病因。然而,非白色念珠菌引起的VVC发作增加,包括光秃念珠菌、热带念珠菌、克鲁氏念珠菌和假丝念珠菌。在这项研究中,从有阴道炎症状的患者中获得的总共100株念珠菌进行了评估。采用对照肉汤微量稀释法测定念珠菌对两性霉素B、伊曲康唑、氟康唑、酮康唑、伏立康唑和卡泊芬净的敏感性。调查了患者的危险因素和人口学特征以及鉴定的念珠菌种类。100株念珠菌中,白色念珠菌47株(47%)、光秃念珠菌43株(43%)、克氏念珠菌5株(5%)、克氏念珠菌2株(2%)、热带念珠菌2株(2%)、吉列蒙地念珠菌1株(1%)。念珠菌对卡泊真菌素、氟康唑、伊曲康唑、伏立康唑、酮康唑和两性霉素B的敏感性分别为75%、35%、27%、80%、97%和100%。此外,属于某些风险群体的患者(如既往使用抗生素的患者和复发病例)的抗真菌敏感性存在显着差异。非白色念珠菌种类的患病率和抗真菌药,特别是对唑类药物的耐药性都在增加,应严格监测某些危险因素。
{"title":"An Epidemiologic Analysis of Vulvovaginal Candidiasis and Antifungal Susceptibilities","authors":"Fadile Gaye Hösükoğlu, F. Ekşi, Mehmet Erinmez, M. Uğur","doi":"10.1097/IM9.0000000000000095","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000095","url":null,"abstract":"Abstract Inflammation of the vagina and vulva caused by Candida is called vulvovaginal candidiasis (VVC). Risk factors for VVC include pregnancy, diabetes mellitus, frequent oral sexual intercourse, and the use of tight synthetic underwear and systemic antibiotics. Candida albicans, which belongs to the normal flora of the vagina, is the most common cause of VVC. However, an increase in VVC episodes caused by non-albicans Candida species, including Candida glabrata, Candida tropicalis, Candida krusei and Candida parapsilosis, has been reported. In this study, a total of 100 Candida isolates obtained from patients with vaginitis symptoms were evaluated. The susceptibility of the Candida strains to amphotericin B, itraconazole, fluconazole, ketoconazole, voriconazole and caspofungin was investigated using the reference broth microdilution method. Risk factors and demographic characteristics of the patients and the identified Candida species were also investigated. Among the 100 Candida strains isolated from vaginal samples, 47 (47%) were C. albicans, 43 (43%) C. glabrata, 5 (5%) C. kefyr, 2 (2%) C. krusei, 2 (2%) C. tropicalis and 1 (1%) was Candida guilliermondii. The incidences of Candida susceptibility to caspofungin, fluconazole, itraconazole, voriconazole, ketoconazole and amphotericin B were 75%, 35%, 27%, 80%, 97% and 100%, respectively. Also, there was a significant difference in antifungal susceptibility among patients belonging to certain risk groups, such as patients previously using antibiotics and recurrent cases. Prevalence of non-albicans Candida species and antifungal resistance, especially against azoles, are both increasing, and certain risk factors should be monitored strictly.","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"131 - 136"},"PeriodicalIF":0.0,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47603171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Nitroxoline Drug Combinations Are More Active Than Lyme Antibiotic Combination and Can Eradicate Stationary-Phase Borrelia burgdorferi 硝基喹啉药物联用比莱姆病抗生素联用更有效,可根除静止期伯氏疏螺旋体
Q3 INFECTIOUS DISEASES Pub Date : 2022-07-26 DOI: 10.1097/IM9.0000000000000096
Hector Alvarez-Manzo, Yumin Zhang, Ying Zhang
Abstract Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Despite the standard 2–4 weeks' antibiotic treatment, approximately 10%–20% of patients will develop posttreatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not effectively killed by the current LD antibiotics. In this study, we evaluated nitroxoline, an antibiotic used to treat urinary tract infections, for its activity against a stationary-phase culture enriched with persister forms of B. burgdorferi. Nitroxoline was found to be more active than doxycycline and equally active as cefuroxime (standard LD antibiotics) against B. burgdorferi. Importantly, the nitroxoline two-drug combinations nitroxoline + cefuroxime and nitroxoline + clarithromycin, as well as the nitroxoline three-drug combination nitroxoline + cefuroxime + clarithromycin, were as effective as the persister drug daptomycin-based positive control three-drug combination cefuroxime + doxycycline + daptomycin, completely eradicating stationary-phase B. burgdorferi in the drug-exposure experiments and preventing regrowth in the subculture study. Future studies should evaluate these promising drug combinations in a persistent LD mouse model.
摘要由伯氏疏螺旋体引起的莱姆病(LD)是美国和欧洲最常见的媒介传播疾病。尽管进行了标准的2-4周抗生素治疗,但约有10%-20%的患者会在治疗后出现LD综合征,这种情况尚不清楚。其中一个可能的原因被认为是存在目前LD抗生素不能有效杀死的伯氏双歧杆菌。在这项研究中,我们评估了用于治疗尿路感染的抗生素硝基索啉对富含伯氏菌持久型的固定相培养物的活性。Nitroxoline被发现比多西环素更具活性,并且与头孢呋辛(标准LD抗生素)对伯氏菌的活性相同。重要的是,硝基索啉两种药物组合硝基索啉+头孢呋辛和硝基索林+克拉霉素,以及硝基索啉三种药物组合硝索啉+头孢呋辛+克拉霉素与基于达托霉素的持续药物阳性对照三种药物联合头孢呋辛+多西环素+达托霉素一样有效,在药物暴露实验中完全根除固定相伯氏芽孢杆菌,并在继代培养研究中防止其再生。未来的研究应该在持久性LD小鼠模型中评估这些有前景的药物组合。
{"title":"Nitroxoline Drug Combinations Are More Active Than Lyme Antibiotic Combination and Can Eradicate Stationary-Phase Borrelia burgdorferi","authors":"Hector Alvarez-Manzo, Yumin Zhang, Ying Zhang","doi":"10.1097/IM9.0000000000000096","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000096","url":null,"abstract":"Abstract Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Despite the standard 2–4 weeks' antibiotic treatment, approximately 10%–20% of patients will develop posttreatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not effectively killed by the current LD antibiotics. In this study, we evaluated nitroxoline, an antibiotic used to treat urinary tract infections, for its activity against a stationary-phase culture enriched with persister forms of B. burgdorferi. Nitroxoline was found to be more active than doxycycline and equally active as cefuroxime (standard LD antibiotics) against B. burgdorferi. Importantly, the nitroxoline two-drug combinations nitroxoline + cefuroxime and nitroxoline + clarithromycin, as well as the nitroxoline three-drug combination nitroxoline + cefuroxime + clarithromycin, were as effective as the persister drug daptomycin-based positive control three-drug combination cefuroxime + doxycycline + daptomycin, completely eradicating stationary-phase B. burgdorferi in the drug-exposure experiments and preventing regrowth in the subculture study. Future studies should evaluate these promising drug combinations in a persistent LD mouse model.","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"124 - 130"},"PeriodicalIF":0.0,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47478654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation: Diagnosis and Treatment Protocol for COVID-19 (Trial Version 9) 《新冠肺炎诊疗方案(试行版9)》
Q3 INFECTIOUS DISEASES Pub Date : 2022-07-26 DOI: 10.1097/IM9.0000000000000093
S. van der Veen
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the β-genus coronaviruses. It has an envelope, and the virus particle is round or oval, with a diameter ranging from 60 to 140 nm. The genome of SARS-CoV-2 contains five essential genes, which encode four structural proteins, namely, the nucleoprotein (N) protein, the envelope (E) protein the matrix protein (M), and the spike (S) protein and an RNA-dependent RNA polymerase (RdRp). The RNA genome is wrapped in the N protein, forming a nucleocapsid surrounded by lipid bilayer membrane, in which the E protein, theMprotein and the S protein are embedded. The S protein interacts with angiotensin-converting enzyme 2 (ACE2) to enter cells. When isolated and cultured in vitro, SARS-CoV-2 can be found in human respiratory epithelial cells in approximately 96 hours; nevertheless, it takes approximately 4–6 days for the virus to be found if isolated and cultured in Vero E6 and Huh-7 cell lines. Similar as observed for other viruses, mutations can occur in the genome of SARS-CoV-2, some ofwhichmay result in changes in the biological characteristics of the virus, thus attracting extensive attention. For instance, changes in the affinity of the S protein for ACE2 can affect the ability of the virus to invade host cells, the ability to replicate and spread, the production of antibodies in convalescent patients and vaccinated people, and the neutralization ability of antibody drugs. Five variants of concern, namely, alpha, beta, gamma, delta, and omicron, have been proposed by the World HealthOrganization. At present, the omicron variant has replaced the delta variant as the main epidemic variant. Evidence has shown that compared with the delta variant, the omicron variant displays stronger transmissibility and weaker pathogenicity. For the omicron variant, the diagnostic accuracy of polymerase chain reaction (PCR)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)属于β属冠状病毒。它有一个包膜,病毒颗粒为圆形或椭圆形,直径在60至140纳米之间。SARS-CoV-2基因组包含5个必需基因,分别编码核蛋白(N)蛋白、包膜蛋白(E)蛋白、基质蛋白(M)、刺突蛋白(S)和RNA依赖性RNA聚合酶(RdRp) 4种结构蛋白。RNA基因组包裹在N蛋白中,形成一个被脂质双层膜包围的核衣壳,其中嵌入了E蛋白、m蛋白和S蛋白。S蛋白与血管紧张素转换酶2 (ACE2)相互作用进入细胞。在体外分离和培养时,SARS-CoV-2可在大约96小时内在人呼吸道上皮细胞中发现;然而,如果在Vero E6和Huh-7细胞系中分离和培养,大约需要4-6天才能发现病毒。与观察到的其他病毒类似,SARS-CoV-2的基因组可能发生突变,其中一些突变可能导致病毒生物学特性的变化,从而引起广泛关注。例如,S蛋白对ACE2亲和力的改变会影响病毒侵入宿主细胞的能力、复制和传播的能力、恢复期患者和接种者体内抗体的产生以及抗体药物的中和能力。世界卫生组织提出了五种变体,即α、β、γ、δ和omicron。目前,组粒变异已取代delta变异成为主要的流行变异。有证据表明,与δ型相比,组粒型具有更强的传播力和更弱的致病性。对于组粒变异,聚合酶链反应(PCR)的诊断准确性
{"title":"Translation: Diagnosis and Treatment Protocol for COVID-19 (Trial Version 9)","authors":"S. van der Veen","doi":"10.1097/IM9.0000000000000093","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000093","url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the β-genus coronaviruses. It has an envelope, and the virus particle is round or oval, with a diameter ranging from 60 to 140 nm. The genome of SARS-CoV-2 contains five essential genes, which encode four structural proteins, namely, the nucleoprotein (N) protein, the envelope (E) protein the matrix protein (M), and the spike (S) protein and an RNA-dependent RNA polymerase (RdRp). The RNA genome is wrapped in the N protein, forming a nucleocapsid surrounded by lipid bilayer membrane, in which the E protein, theMprotein and the S protein are embedded. The S protein interacts with angiotensin-converting enzyme 2 (ACE2) to enter cells. When isolated and cultured in vitro, SARS-CoV-2 can be found in human respiratory epithelial cells in approximately 96 hours; nevertheless, it takes approximately 4–6 days for the virus to be found if isolated and cultured in Vero E6 and Huh-7 cell lines. Similar as observed for other viruses, mutations can occur in the genome of SARS-CoV-2, some ofwhichmay result in changes in the biological characteristics of the virus, thus attracting extensive attention. For instance, changes in the affinity of the S protein for ACE2 can affect the ability of the virus to invade host cells, the ability to replicate and spread, the production of antibodies in convalescent patients and vaccinated people, and the neutralization ability of antibody drugs. Five variants of concern, namely, alpha, beta, gamma, delta, and omicron, have been proposed by the World HealthOrganization. At present, the omicron variant has replaced the delta variant as the main epidemic variant. Evidence has shown that compared with the delta variant, the omicron variant displays stronger transmissibility and weaker pathogenicity. For the omicron variant, the diagnostic accuracy of polymerase chain reaction (PCR)","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"94 - 102"},"PeriodicalIF":0.0,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42197429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management 将NAFLD更名为MAFLD:诊断、病理生理学、治疗和管理方面的优势和潜在变化
Q3 INFECTIOUS DISEASES Pub Date : 2022-05-03 DOI: 10.1097/IM9.0000000000000089
F. Rui, Hongli Yang, Xinyu Hu, Q. Xue, Yayun Xu, Junping Shi, Jie Li
Abstract In recent years, with the increasing incidence of obesity and other metabolic diseases, the prevalence of non-alcoholic fatty liver disease (NAFLD) has increased and it has become a major health problem affecting more than one quarter of the world's population. Recently, experts reached a consensus that NAFLD does not reflect the current knowledge, and metabolic dysfunction-associated fatty liver disease (MAFLD) was suggested as a more appropriate term. MAFLD is not just a simple renaming of NAFLD. The definition of MAFLD allows a patient to have dual (or more) etiologies for their liver disease, which will help to exclude more heterogeneous patients. In this review, we introduce the significant differences between the definitions of NAFLD and MAFLD. In addition, we also describe the advantages of the term MAFLD in the pathophysiology, therapy, and patient management.
摘要近年来,随着肥胖和其他代谢性疾病的发病率不断上升,非酒精性脂肪肝(NAFLD)的患病率也在上升,已成为影响世界四分之一以上人口的主要健康问题。最近,专家们达成共识,认为NAFLD并不能反映目前的知识,代谢功能障碍相关脂肪肝(MAFLD)被认为是一个更合适的术语。MAFLD不仅仅是NAFLD的简单更名。MAFLD的定义允许患者的肝病有双重(或多种)病因,这将有助于排除更多异质性患者。在这篇综述中,我们介绍了NAFLD和MAFLD的定义之间的显著差异。此外,我们还描述了MAFLD一词在病理生理学、治疗和患者管理方面的优势。
{"title":"Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management","authors":"F. Rui, Hongli Yang, Xinyu Hu, Q. Xue, Yayun Xu, Junping Shi, Jie Li","doi":"10.1097/IM9.0000000000000089","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000089","url":null,"abstract":"Abstract In recent years, with the increasing incidence of obesity and other metabolic diseases, the prevalence of non-alcoholic fatty liver disease (NAFLD) has increased and it has become a major health problem affecting more than one quarter of the world's population. Recently, experts reached a consensus that NAFLD does not reflect the current knowledge, and metabolic dysfunction-associated fatty liver disease (MAFLD) was suggested as a more appropriate term. MAFLD is not just a simple renaming of NAFLD. The definition of MAFLD allows a patient to have dual (or more) etiologies for their liver disease, which will help to exclude more heterogeneous patients. In this review, we introduce the significant differences between the definitions of NAFLD and MAFLD. In addition, we also describe the advantages of the term MAFLD in the pathophysiology, therapy, and patient management.","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"49 - 55"},"PeriodicalIF":0.0,"publicationDate":"2022-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49431103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Advances in HIV Eradication Strategies 艾滋病毒根除战略进展
Q3 INFECTIOUS DISEASES Pub Date : 2022-05-03 DOI: 10.1097/IM9.0000000000000088
Qingmin Mei, Wei Wang, Jianjun Wu, Yong Gao
Abstract Although the advent of combination antiretroviral therapy can efficiently suppress human immunodeficiency virus (HIV) replication, a complete cure for HIV infection cannot be achieved due to the existence of latent viral reservoirs. In recent years, investigation of HIV cure strategies has become a hot topic in the field. In this article, we review the major barriers to HIV cure, compare the progress and challenges of non-specific and specific latent reversal agents in curing HIV, and discuss possible solutions to the current problems.
摘要尽管联合抗逆转录病毒疗法的出现可以有效抑制人类免疫缺陷病毒(HIV)的复制,但由于潜在病毒库的存在,无法完全治愈HIV感染。近年来,艾滋病病毒治疗策略的研究已成为该领域的热点。在这篇文章中,我们回顾了艾滋病病毒治疗的主要障碍,比较了非特异性和特异性潜在逆转剂在治疗艾滋病病毒方面的进展和挑战,并讨论了当前问题的可能解决方案。
{"title":"Advances in HIV Eradication Strategies","authors":"Qingmin Mei, Wei Wang, Jianjun Wu, Yong Gao","doi":"10.1097/IM9.0000000000000088","DOIUrl":"https://doi.org/10.1097/IM9.0000000000000088","url":null,"abstract":"Abstract Although the advent of combination antiretroviral therapy can efficiently suppress human immunodeficiency virus (HIV) replication, a complete cure for HIV infection cannot be achieved due to the existence of latent viral reservoirs. In recent years, investigation of HIV cure strategies has become a hot topic in the field. In this article, we review the major barriers to HIV cure, compare the progress and challenges of non-specific and specific latent reversal agents in curing HIV, and discuss possible solutions to the current problems.","PeriodicalId":73374,"journal":{"name":"Infectious microbes & diseases","volume":"4 1","pages":"64 - 70"},"PeriodicalIF":0.0,"publicationDate":"2022-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41803587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infectious microbes & diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1